J. S. Archer and R. J. Chang, Hirsutism and acne in polycystic ovary syndrome, Best Pract Res Clin Obstet Gynaecol, vol.18, pp.737-54, 2004.

A. O. Arowojolu, M. F. Gallo, L. M. Lopez, and D. A. Grimes, Combined oral contraceptive pills for treatment of acne, Cochrane Database Syst Rev, vol.7, p.4425, 2012.

P. G. Artini, D. Berardino, O. M. , P. Fi, A. D. Genazzani et al., Endocrine and clinical effects of myo-inositol administration in policystic ovary syndrome A randomized study, Gynecol. Endocrinol, vol.29, pp.375-384, 2013.

, Association canadienne de dermatologie. Peau, cheveux et ongles: stades de l'acné

. Ottawa, Image, stades de l'acné, 2016.

, Association Française de Sécurité Sanitaire des Produits de Santé. Traitement de l'acné par voie locale et générale. Recommandations, 2007.

N. Auffret, J. Revuz, and B. Dréno, Opinion d'expert: Algorithme de traitement de l'acné juvénile du visage

, Annales De Dermatologie Et De Venereologie, 2011.

R. Azziz, C. E. Dewailly, and D. , Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess. Society guideline, J Clin Endocrinol Metab, vol.91, pp.4237-4282, 2006.

R. Azziz and M. D. Kashar-miller, Family history as a risk factor for the polycystic ovary syndrome, J Pediatr Endocrinol Metab, vol.13, issue.5, pp.1303-1309, 2000.

R. Azziz, M. H. Nicolas, S. Bernard, P. Moulin, and M. Pugeat, Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebocontrolled trial, J Clin Endocrinol Metab, vol.86, issue.4, pp.1626-1658, 2001.

R. Azziz, The evaluation and management of hirsutism, Obstet Gynecol, vol.101, pp.995-1007, 2003.

, monkeys exposed to prenatal androgen excess, Fertil Steril, vol.77, issue.1, pp.167-72, 2002.

J. R. Eisner, D. A. Dumesic, J. W. Kemnitz, and D. H. Abbott, Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys, J Clin Endocrinol Metab, vol.85, issue.3, pp.1206-1216, 2000.

M. W. Elting and T. J. Korsen, Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a dutch PCOS population, Hum Reprod, vol.16, issue.3, pp.556-60, 2001.

F. H. Epstein, Spironolactone and ACE inhibition in chronic renal failure, N Engl J Med, vol.346, pp.456-463, 2002.

G. F. Erickson, Ovarian androgen biosynthesis : endocrine regulation, Androgen excess disorders in women, 1997.

, ESHRE/ASRM sponsored PCOS consensus workshop group, vol.19, pp.41-48, 2004.

E. Pcos,

, Steril, vol.97, pp.28-38, 2012.

, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome, ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, vol.81, pp.19-25, 2004.

L. Falsetti, A. Gambera, L. Legrenzi, C. Iacobello, and G. Bugari, Comparison of finasteride versus flutamide in the treatment of hirsutism, Eur J Endocrinol, vol.141, issue.4, pp.361-368, 1999.

L. Falsetti, F. Ramazzo, and R. B. , Efficacy of combined ethinylestradiol (0.035 mg) and cyproterone acetate (2 mg) in acne and hirsutism in women with polycystic ovary syndrome, J Obstet Gynecol, vol.17, issue.6, pp.565-573, 1977.

M. Faure, Prise en charge de l'acné chez l'adolescent. Archives De Pédiatrie, vol.14, pp.1152-1158, 2007.

B. C. Fauser, T. D. Pache, S. W. Lamberts, W. C. Hop, F. H. De-jong et al., Serum bioactive and immunoreactive luteinizing hormone and folliclestimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease, J Clin Endocrinol Metab, vol.73, pp.811-818, 1991.

D. Ferriman and J. D. Gallwey, Clinical assessment of body hair growth in women, J Clin Endocrinol, vol.21, pp.1440-1447, 1961.

N. Féton-danou, Annales De Dermatologie Et De Venereologie, vol.137, pp.15-18, 2010.

J. S. Flier, Syndromes of insulin resistance. From patient to gene and back again, Diabetes, vol.41, pp.1207-1226, 1992.

J. C. Florez, Genetic susceptibility for polycystic ovary syndrome on chromosome 19: advances in the genetic dissection of complex reproductive traits, J Clin Endocrinol Metab, vol.90, issue.12, pp.6732-6736, 2005.

R. B. Fogel, A. Malhotra, G. Pillar, S. D. Pittman, A. Dunaif et al., Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome, J Clin Endocrinol Metab, vol.86, issue.3, pp.1175-80, 2001.

S. Franks, H. Mason, and D. White, Etiology of anovulation in polycystic ovary syndrome, Steroids, vol.63, pp.306-313, 1998.

S. Franks, Polycystic ovary syndrome, N Engl J Med, vol.333, pp.853-61, 1995.
URL : https://hal.archives-ouvertes.fr/hal-01859437

J. F. Froen, M. Arnestad, and K. Frey, Risk factors for sudden intrauterine unexplained death : epidemiologic characteristics of singleton cases in Oslo, Am J Obstet Gynecol, vol.184, pp.694-702, 1986.

A. Gamberini, C. Pelusi, V. Vicennati, U. Pagotto, and R. Pasquali, Obesity and the polycystic ovary syndrome, Int J Obesity, vol.26, pp.883-96, 2002.

A. Gambineri, C. Pelusi, and S. Genghini, Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome, Clin Endocrinol (Oxf), vol.60, pp.241-250, 2004.

F. Gametix, , 2017.

. Disponible,

A. D. Genazzani, Differential insulin response to myo-inositol administration in obese polycystic ovary

A. D. Genazzani, C. Lanzoni, F. Ricchieri, and V. M. Jasonni, Myo-Inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome

, Gynecol. Endocrinol, vol.24, pp.139-183, 2008.

S. Gerli, M. Mignosa, D. Renzo, and G. C. , Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebocontrolled trial, Eur. Rev. Med. Pharmacol. Sci, vol.7, pp.151-160, 2003.

S. Gerli, E. Papaleo, A. Ferrari, D. Renzo, and G. C. ,

. Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS, Eur. Rev

, Med. Pharmacol. Sci, vol.11, pp.347-54, 2007.

M. Gfesser and W. I. Worret, Seasonal variations in the severity of acne vulgaris, Int J Dermatol, vol.35, pp.116-123, 1996.

C. J. Glueck, R. Papanna, P. Wang, and N. Goldenberg, SieveSmith L. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome, Hum Reprod Update, vol.12, pp.673-83, 2006.

C. J. Glueck, L. Sieve, B. Zhu, and P. Wang, Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and firsttrimester miscarriage in women with polycystic ovary syndrome, Metabolism, vol.55, issue.3, pp.345-52, 2006.

C. J. Glueck, P. Wang, R. N. Fontaine, L. Sieve-smith, T. Tracy et al., Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome, Metabolism, vol.48, issue.12, pp.1589-95, 1999.

V. Gomel and H. Yarali, Surgical treatment of polycystic ovary syndrome associated with infertility, Reprod Biomed Online, vol.9, issue.1, pp.35-42, 2004.

M. Gopal, S. Duntley, M. Uhles, and H. Attarian, The role of obesity in the increased prevalence of obstructive sleep apnea syndrome in patients with polycystic ovarian syndrome, Sleep Med, vol.3, issue.5, pp.401-405, 2002.

P. T. Goud, A. P. Goud, and L. Leybaert, Inositol 1,4,5trisphosphate receptor function in human oocytes: calcium responses and oocyte activationrelated phenomena induced by photolytic release of InsP3 are blocked by a specific antibody to the type I receptor

, Mol Hum Reprod, vol.8, pp.912-920, 2002.

P. T. Goud, A. P. Goud, V. Oostveldt, and P. , Presence and dynamic redistribution of type I inositol 1,4,5trisphosphate receptors in human oocytes and embryos during in-vitro maturation, fertilization and early cleavage divisions, Mol Hum Reprod, vol.5, pp.441-51, 1999.

D. Guerrero, Avant-propos: Approche dermocosmétique de l'acné chez le dermatologue, vol.137, pp.76-80, 2010.

D. S. Guzick, Ovulation induction management of PCOS, Clin Obstet Gynecol, vol.50, pp.255-67, 2007.

. Gynositol, , 2017.

. Disponible,

M. Gysler, C. M. March, M. Jr, D. R. Bailey, and E. J. , A decade's experience with an individualized clomiphene treatment regimen including its effect on the postcoital test, Fertil Steril, vol.37, issue.2, pp.161-168, 1982.

D. J. Haisenleder, A. C. Dalkin, G. A. Ortolano, J. C. Marshall, and M. A. Shupnik, A pulsatile gonadotropin-releasing hormone stimulus is required to increase transcription of the gonadotropin subunit genes: evidence for differential regulation of transcription by pulse frequency in vivo, Endocrinology, vol.128, issue.1, pp.509-526, 1991.

J. Hammersteim, J. Meckies, I. Leo-rossberg, L. Moltz, and F. Zielske, Use of cyproterone acetate in the treatment of acne, hirsutism and virilism, J Steroid Biochem, vol.6, pp.827-863, 1975.

I. Hamzavi, E. Tan, J. Shapiro, and H. Lui, A randomized bilateral vehiclecontrolled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women, J Am Acad Dermatol, vol.57, pp.54-63, 2007.

P. Hardiman, O. C. Pillay, and W. Atiomo, Polycystic ovary syndrome and endometrial carcinoma, Lancet, vol.361, issue.9371, pp.1810-1812, 2003.

R. Hart, M. Hickey, S. Franks, and . Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome, Best Pract Res Clin Obstet Gynaecol, vol.18, pp.671-83, 2004.

, Contraceptifs oraux oestroprogestatifs: préferez les "pilules" de 1ère ou 2è génération. Fiche de Bon Usage du Médicament, 2012.

, Healthwise: Health information and tools: Body fat distribution, Image, 2015.

B. Hédon, J. N. Hugues, and J. C. Emperaire, A comparative prospective study of a chronic low-dose versus a conventional ovulation stimulation regimen using r-hFSH (Gonal-F®) in anovulatory infertile women, Hum Reprod, vol.10, pp.2688-92, 1998.

D. Heimark, J. Mcallister, and J. Larner, Decreased myoinositol to chiro-inositol (M/C) ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls, Endocrine Journal

T. E. Hickey, R. S. Legro, and R. J. Norman, Epigenetic modification of the X chromosome influences susceptibility to polycystic ovary syndrome, J Clin Endocrinol Metab, vol.91, pp.2789-91, 2006.

S. G. Hillier, Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis, Hum Reprod, vol.9, pp.188-91, 1994.

S. G. Hillier, Intrafollicular paracrine function of ovarian androgen, J Steroid Biochem, vol.27, pp.351-358, 1987.

M. J. Himelein and S. S. Thatcher, Polycystic ovary syndrome and mental health: A review, Obstet Gynecol Surv, vol.61, pp.723-755, 2006.

R. R. Holman, S. K. Paul, M. A. Bethel, D. R. Matthews, and H. A. Neil, 10 year follow-up of intensive glucose control in type 2 diabetes, N Engl J Med, vol.359, pp.1577-89, 2008.

. Holte, Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables

, Clin Endocrino.l, vol.41, pp.463-71, 1994.

B. J. Holub, Metabolism and function of myo-inositol and inositol phospholipids, Ann Rev Nutr, vol.6, pp.563-97, 1986.

R. Homburg, N. A. Armar, A. Eshel, J. Adams, and H. S. Jacobs, Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome, BMJ, vol.297, issue.6655, pp.1024-1030, 1988.

R. Homburg and C. M. Howles, Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome : rationale, results, reflections and refinements, Hum Reprod Update, vol.5, pp.493-99, 1999.

R. Homburg, A. Ray, and P. Bhide, The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study, Hum Reprod, vol.28, pp.1077-83, 2013.

R. Homburg, The management of infertility associated with polycystic ovary syndrome, Reprod Biol Endocrinol, vol.1, p.109, 2003.

K. Horie, K. Takakura, H. Fujiwara, H. Suginami, S. Liao et al., Immunohistochemical localization of androgen receptor in the human ovary throughout the menstrual cycle in relation to oestrogen and progesterone receptor expression, Hum Reprod, vol.7, pp.184-90, 1992.

J. G. Hreinsson, J. E. Scott, C. Rasmussen, M. L. Swahn, A. J. Hsueh et al., Growth differentiation factor-9 promotes the growth, development, and survival of human ovarian follicles in organ culture, J Clin Endocrinol Metab, vol.87, pp.316-337, 2002.

L. C. Huang, M. C. Fonteles, and D. B. Houston, Chiroinositol deficiency and insulin resistance. III. Acute glycogenic and hypo-glycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivo

, Endocrinology, vol.132, pp.652-659, 1993.

J. N. Hugues, Les "step protocoles, Contracept Fertil Sex, vol.26, pp.307-318, 1998.

M. G. Hull, Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies, Gynecol Endocrinol, vol.1, issue.3, pp.235-280, 1987.

L. Ibáñez, R. Díaz, and A. López-bermejo, Clinical spectrum of premature pubarche : links to metabolic syndrome and ovarian hyperandrogenism, Rev Endocr Metab Disord, vol.10, pp.63-76, 2009.

L. Ibanez, A. Jaramillo, and F. Ferrer-ade-zegher, Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women, Hum Reprod, vol.20, pp.1833-1839, 2005.

L. Ibanez, C. Valls, N. Potau, M. V. Marcos, and F. De-zegher, Polycystic ovary syndrome after precocious pubarche: ontogeny of the low-birthweight effect, Clin Endocrinol (Oxf), vol.55, issue.5, pp.667-72, 2001.

S. Iliodromiti, T. W. Kelsey, and R. A. Anderson, Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome ? A systematic review and meta-analysis of extracted data, J Clin Endocrinol Metab, vol.98, pp.3332-3372, 2013.

B. Imani, M. J. Eijkemans, and E. R. Velde, A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligo-amenorrheic infertility, Fertil Steril, vol.77, pp.91-98, 2002.

B. Imani, M. J. Eijkemans, E. R. Velde, J. D. Habbema, and B. C. Fauser, Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility, J Clin Endocrinol Metab, 1998.

, Aout, 2016.

V. Insler, Gonadotropin therapy: new trends and insights, Int J Fertil, vol.33, issue.2, pp.85-91, 1988.

, International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome, 2006.

, J Obstet Gynaecol Can, vol.24, issue.1, pp.68-73, 2002.

H. S. Jacobs, Polycystic ovaries and polycystic ovary syndrome, Gynecol Endocrinol, vol.1, pp.113-144, 1987.

J. P. Jacobs, C. A. Szpunar, and M. L. Warner, Use of topical minoxidil therapy for androgenetic alopecia in women, Int J Dermatol, vol.32, issue.10, pp.758-62, 1993.

D. J. Jakubowicz, P. A. Essah, and M. Seppälä, Reduced serum glycodelin and insulin-like growth factorbinding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancy, J Clin Endocrinol Metab, vol.89, pp.833-842, 2004.

D. J. Jakubowicz, M. J. Iuorno, S. Jakubowicz, K. A. Roberts, and J. E. Nestler, Effects of metformin on early pregnancy loss in the polycystic ovary syndrome, J Clin Endocrinol Metab, vol.87, issue.2, pp.524-533, 2002.

S. Jonard and D. Dewailly, The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest, Hum Reprod. Update, vol.10, pp.107-124, 2004.

S. Jonard, Y. Robert, C. Cortet-rudelli, P. Pigny, C. Decanter et al., Ultrasound examination of polycystic ovaries: is it worth counting the follicles?, Hum Reprod, vol.18, pp.598-603, 2003.

G. L. Jones, J. M. Hall, and A. H. Balen, Health-related quality of life measurement in women with polycystic ovary syndrome: a systematic review, Hum Reprod. Update, vol.14, pp.15-25, 2008.

G. Jouve and . Folliculogénèse, UE Biologie de la Reproduction, Université de Rennes, vol.1, p.6, 2015.

M. D. Kahsar-miller, C. Nixon, L. R. Boots, R. C. Go, and R. Azziz, Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS, Fertil Steril, vol.75, issue.1, pp.53-61, 2001.

S. Kashyap, G. A. Wells, and Z. Rosenwaks, Insulinsensitizing agents as primary therapy for patients with polycystic ovarian syndrome, Hum Reprod, vol.19, issue.11, pp.2474-83, 2004.

S. C. Kellett and D. J. Gawkrodger, The psychological and emotional impact of acne and the effect of treatment with isotretinoin, Br J Dermatol, vol.140, pp.273-82, 1999.

C. J. Kelly, A. Speirs, G. W. Gould, J. R. Petrie, H. Lyall et al., Altered vascular function in young women with polycystic ovary syndrome, J Clin Endocrinol Metab, vol.87, issue.2, pp.742-748, 2002.

A. S. Kennington, Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus

, N. Engl. J. Med, vol.323, pp.373-381, 1990.

D. S. Kiddy, D. Hamilton-fairley, and A. Bush, Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome, Clin Endocrinol, vol.36, pp.105-116, 1992.

S. Kirchengast and J. Huber, Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome, Hum Reprod, vol.16, pp.1255-60, 2001.

D. Kopera, Hair reduction: 48 months of experience with 800 nm diode laser, J Cosmet Laser Ther, vol.5, pp.146-155, 2003.

I. P. Kosmas, A. Tatsioni, and H. M. Fatemi, Human chorionic gonadotropin administration vs luteinizing monitoring for intrauterine insemination timing, after administration of clomiphene citrate : a meta-analysis

, Fertil Steril, vol.87, pp.607-619, 2007.

O. Koulouri and G. S. Conway, A systematic review of commonly used medical treatments for hirsutism in women, Clin Endocrinol (Oxf), vol.68, pp.800-805, 2008.

E. Kousta, G. Tolis, and S. Franks, Polycystic Ovary Syndrome. Revised diagnostic criteria and long-term health consequences, Hormones, vol.4, pp.133-180, 2005.

E. Kousta, D. M. White, and S. Franks, Modern use of clomiphene citrate induction of ovulation, Hum Reprod. Update, vol.3, pp.359-65, 1997.

F. Kuttenn, C. Rigaud, and F. Wright, Treatment of hirsutism by oral cyproterone acetate and percutaneous estradiol, J Clin Endocrinol Metab, vol.5, pp.1107-1118, 1980.

A. L. Laborie, . Les, S. Jour-le-jour.-1ère, and 3. Thème, Féminin-Masculin, 2014.

. Disponible,

E. M. Lakryc, E. L. Motta, J. M. Soares, M. A. Haidar, G. R. De-lima et al., The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism, Gynecol Endocrinol, vol.17, pp.57-63, 2003.

S. Lamassiaude-peyramaure, Santé/nature/bien-être : L'acné, des alternatives naturelles à conseiller à l'officine. Actualités Pharmaceutiques, vol.48, pp.38-47, 2009.

J. Larner, D-chiro-inositol : its functional role in insulin action and its deficit in insulin resistance

, J. Exp. Diabetes Res, vol.3, pp.47-60, 2002.

J. S. Laven, A. G. Mulders, J. A. Visser, A. P. Themmen, D. Jong et al., Anti-mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age, J Clin Endocrinol Metab, vol.89, pp.318-341, 2004.

L. Cleach, L. Lebrun-vignes, B. Guillot, and B. , Prise en charge de l'acné

, Traitement de l'acné par voie locale et générale

. Archives-de-pédiatrie, , vol.23, pp.213-234, 2016.

L. Moniteur, Les problèmes capillaires. Rev. Le moniteur des pharmacies, cahier de formation, 2011.

, Quelques réflexions sur l'acné en, 2014.

, Image

. Disponible,

P. Lefebvre, Gynécologie Obstétrique & Fertilité, vol.32, pp.193-201, 2004.

R. S. Legro, H. X. Barnhart, and W. D. Schlaff,

, Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome, N Engl J Med, vol.356, pp.551-66, 2007.

R. S. Legro, A. R. Kunselman, W. C. Dodson, and A. Dunaif, Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome : a prospective, controlled study in 254 aff ected women, J Clin Endocrinol Metab, vol.84, pp.165-174, 1999.

L. L. Levy and J. J. Emer, Female pattern alopecia: current perspectives, Int J Womens Health, vol.5, pp.541-56, 2013.

T. C. Li, Recurrent miscarriage: principles of management, Hum Reprod, vol.13, issue.2, pp.478-82, 1998.

X. Li and R. Shao, PCOS and obesity: insulin resistance might be a common etiology for the development of type I endometrial carcinoma, Am J Cancer Res, 2014.

, Jan, vol.15, issue.1, pp.73-82

T. Liang, C. E. Heiss, S. Ostrove, G. H. Rasmusson, and A. Cheung, Binding of a 4-methyl-4-aza-steroid to 5 alpha-reductase of rat liver and prostate microsomes, Endocrinology, vol.112, pp.1460-1468, 1983.

E. Lopez, J. Gunby, S. Daya, J. J. Parrilla, L. Abad et al., Ovulation induction in women with polycystic ovary syndrome: randomized trial of clomiphene citrate versus low-dose recombinant FSH as first line therapy, Reprod Biomed Online, vol.9, issue.4, pp.382-90, 2004.

J. M. Lord, I. Fligh, and R. J. Norman, Metformin in polycystic ovary syndrome: systematic review and meta-analysis, BMJ, vol.327, issue.7421, pp.951-954, 2003.

K. M. Lowther, V. N. Weitzman, D. Maier, and L. M. Mehlmann, Maturation, fertilization, and the structure and function of the endoplasmic reticulum in cryopreserved mouse oocytes, Biol Reprod, 2009.

V. Lubin, E. Cosson, B. Eyguesier-pfister, J. Chalabreysse, R. Shojai et al., CA-100: Le traitement du diabète gestationnel par myo-inositol permet d'éviter l'insulinothérapie dans ¾ des cas. Résultats d'une étude pilote, Diabetes & Metabolism, vol.42, p.62, 2016.

S. Lumbroso, J. M. Lobaccaro, and C. Sultan, Androgènes chez la femme : biosynthèse et mode d'action

, Reproduction Humaine et Hormones, vol.5, pp.1-6, 1995.

M. Luque-ramirez, C. Mendieta-azcona, F. Alverezblasco, and H. F. Escobar-morreale, Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome, Hum Reprod, vol.22, pp.3197-203, 2007.

D. Maiter, Le syndrome des ovaires micropolykystiques (OMPK): le point de vue de l'endocrinologue. Document présenté lors: Conférence de l'ALFORMEC, Clinique Saint Luc. Figure, p.6, 2011.

K. A. Martin, R. J. Chang, D. A. Ehrmann, L. Ibanez, R. A. Lobo et al., Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline, J Clin Endocrinol Metab, vol.93, issue.4, pp.1105-1125, 2008.
URL : https://hal.archives-ouvertes.fr/hal-01847374

, Martindale: The Complete Drug Reference. Clomifene citrate: Adverse effects

B. Matard and P. Reygagne, EMCCosmétologie et Dermatologie esthétique, 2002.

K. J. Mather and F. Kwan, Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity, 2000.

A. R. Mclellan, J. Rentoul, R. Mackie, and G. T. Mcinnes, Lack of effect of spironolactone on hair shaft diameter in hirsute females, Postgrad Med J, vol.65, pp.459-62, 1989.

A. G. Messenger and J. Rundegren, Minoxidil: mechanisms of action on hair growth, Br J Dermatol, 2004.

N. Midoun-mouaci, Editions Med'Com, 2008.

M. Minozzi, D. 'andrea, G. Unfer, and V. , Treatment of hirsutism with myo-inositol: a prospective clinical study, Reprod. Biomed, vol.17, pp.579-82, 2008.

M. F. Mitwally, S. F. Witchel, and R. F. Casper, Troglitazone: a possible modulator of ovarian steroidogenesis, J Soc Gynecol Investig, vol.9, issue.3, pp.163-170, 2002.

P. Moghetti, R. Castello, C. Negri, F. Tosi, F. Perrone et al., Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6 month trial, followed by open, longterm clinical evaluation, J Clin Endocrinol Metab, vol.85, pp.139-185, 2000.

P. Moghetti, F. Tosi, A. Tosti, C. Negri, C. Misciali et al., Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebocontrolled trial, J Clin Endocrinol Metab, vol.85, pp.89-94, 2000.

E. Moll, P. M. Bossuyt, and J. C. Korevaar, Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial, BMJ, vol.332, p.1485, 2006.

L. J. Moran, M. L. Misso, and R. A. Wild, Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome : a systematic review and meta-analysis, Hum Reprod. Update, vol.16, pp.347-63, 2010.

G. Morgante, R. Orvieto, A. Di-sabatino, M. C. Musacchio, and V. De-leo, The role of inositol supplementation in patients with polycystic ovary syndrome

, Fertil. Steril, vol.95, pp.2642-2646, 2011.

I. I. Muderris, F. Bayram, and M. Guven, Treatment of hirsutism with lowest-dose flutamide (62.5 mg/day)

, Gynecol Endocrinol, vol.14, issue.1, pp.38-41, 2000.

A. G. Mulders, J. S. Laven, and M. J. Eijkemans, Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility : a meta-analysis, Hum Reprod. Update, vol.9, pp.429-478, 2003.

A. A. Murray, R. G. Gosden, V. Allison, and N. Spears, Effect of androgens on the development of mouse follicles growing in vitro, J Reprod Fertil, vol.113, pp.27-33, 1998.

R. Nahum, K. J. Thong, and S. G. Hillier, Metabolic regulation of androgen production by human thecal cells in vitro, Hum Reprod, vol.10, pp.75-81, 1995.

V. L. Nelson, R. S. Legro, and J. F. Strauss,

V. L. Nelson, Q. Kn, K. N. Rosenfield, R. L. Wood, J. R. Penning et al., The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome, J Clin Endocrinol Metab, vol.86, issue.12, pp.5925-5958, 2001.

J. E. Nestler, D. J. Jakubowicz, W. S. Evans, and R. Pasquali, Effects of metformin on spontaneous and clomipheneinduced ovulation in the polycystic ovary syndrome, N Engl J Med, vol.338, pp.1876-80, 1998.

J. E. Nestler and D. J. Jakubowicz, Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome, N Engl J Med, vol.335, pp.617-640, 1996.

J. E. Nestler, L. P. Powers, and D. W. Matt, A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome, J Clin Endocrinol Metab, vol.72, pp.83-92, 1991.

F. Nobels and D. Dewailly, Puberty and polycystic ovarian syndrome: the insulin/insulin-like growth factor I hypothesis, Fertil Steril, vol.58, pp.655-66, 1992.

R. J. Norman, D. Dewailly, and R. S. Legro, Polycystic ovary syndrome, Lancet, vol.370, pp.685-97, 2007.

O. 'brien, R. C. Cooper, M. E. Murray, and R. M. , the treatment of hirsutism, J Clin Endocrinol Metab, vol.72, pp.1008-1021, 1991.

J. Ohl, Figure 1 : Représentation schématique de différents protocoles de stimulation de l'ovulation par la FSH recombinante, vol.235, p.8, 2004.

E. A. Olsen, F. E. Dunlap, and T. Funicella, A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men, J. Am

. Acad, , vol.47, pp.377-85, 2002.

F. Orio, F. Giallauria, S. Palomba, T. Cascella, F. Manguso et al., Cardiopulmonary impairment in young women with polycystic ovary syndrome, J Clin Endocrinol Metab, vol.91, issue.8, pp.2967-71, 2006.

F. Orio, S. Palomba, T. Cascella, D. Simone, B. et al., Early impairment of endothelial structure and function in young normalweight women with polycystic ovary syndrome, J Clin Endocrinol Metab, vol.89, issue.9, pp.4588-93, 2004.

F. Orio, S. Palomba, L. Spinelli, T. Cascella, L. Tauchmanova et al., The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study, J Clin Endocrinol Metab, vol.89, issue.8, pp.3696-701, 2004.

T. D. Pache, S. Chadha, L. J. Gooren, W. C. Hop, K. W. Jaarsma et al., Ovarian morphology in long-term androgen-treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome?, Histopathology, vol.19, issue.5, pp.445-52, 1991.

S. Palomba, A. Falbo, F. Zullo, and F. Orio, Evidence-based and potential benefits of metformin in polycystic ovary syndrome, Endocr Rev, vol.30, pp.1-50, 2009.

S. Palomba, T. Russo, and F. Orio, Uterine effects of clomiphene citrate in women with polycystic ovary syndrome : a prospective controlled study, Hum Reprod, vol.21, pp.2823-2832, 2006.

D. Paitraud, Androcur 50 mg comprimé sécable (cyprotérone) simplification du schéma thérapeutique

E. Papaleo, V. Unfer, J. P. Baillargeon, D. Santis, L. Fusi et al., Myo-Inositol in patients with polycystic ovary syndrome: a novel method for

F. Paris, F. Rabvoelina, P. Balaguer, A. Bacquet, and C. Sultan, Antiandrogenic activity of norgestimate in human androgen-dependent stable-transfected cell line

, Gynecol Endocrinol, vol.23, pp.193-200, 2007.

C. R. Parker, Normal regulation of adrenal androgen production, Androgen excess disorders in women, pp.23-35, 1997.

R. Pasquali, C. Pelusi, and S. Genghini, Obesity and reproductive disorders in women, Hum Reprod. Update, vol.9, pp.359-72, 2003.

F. Pellestor, Histologie des appareils génitaux. Module intégré Génétique Reproduction Développement de PCEM 2, vol.1, p.32, 2008.

J. Peter, Le syndrome des ovaires polykystiques (OPK) et l'infertilité

, Aspect échographique typique d'un ovaire polykystique, Image

A. Picardi, D. Abeni, and C. F. Melchi, Psychiatric morbidity in dermatological outpatients: an issue to be recognized, Br J Dermatol, vol.143, pp.983-91, 2000.

T. Pierpont, M. Keigue, P. M. Isaacs, and A. J. , Mortality of women with polycystic ovary syndrome at longterm follow-up, J Clin Epidemiol, vol.51, pp.518-86, 1998.

P. Pigny, S. Jonard, Y. Robert, and D. Dewailly, Serum antimullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome

, J Clin Endocrinol Metab, vol.91, pp.941-946, 2006.

P. Pigny, E. Merlen, and Y. Robert, Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome : relationship to the ovarian follicle excess and to the follicular arrest, J Clin Endocrinol Metab, vol.88, pp.5957-62, 2003.

O. C. Pillay, T. Fong, L. F. Crow, J. C. Benjamin, E. Mould et al., The association between polycystic ovaries and endometrial cancer, Hum Reprod, vol.21, issue.4, pp.924-933, 2006.

F. Pillon and F. Allaert, Compléments alimentaires: Rôle de la complémentation orale pour lutter contre la chute de cheveux. Actualités Pharmaceutiques, pp.39-40, 2011.

S. Plymate, Regulation of serum sex hormone binding globulin levels in PCOS, Androgen excess disorders in women, pp.497-505, 1997.

L. Poretsky, N. A. Cataldo, and Z. Rosenwaks, The insulin-related ovarian regulatory system in hand disease, Endocr Rev, vol.20, pp.535-82, 1999.

V. H. Price, E. Menefee, and P. C. Strauss, Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment, J. Am. Acad. Dermatol, vol.41, pp.717-738, 1999.

F. Procrea, , 2017.

M. Pugeat, J. C. Crave, and M. Elmidani, Pathophysiology of sex hormone binding globulin (SHBG) : relation to insulin, J Steroid Biochem Mol Biol, vol.40, pp.841-850, 1991.

M. Pugeat, H. Déchaud, V. Raverot, A. Denuzière, R. Cohen et al., Recommendations for investigation of hyperandrogenism, Ann Endocrinol, vol.71, pp.2-7, 2010.

P. A. Radon, M. J. Mcmahon, and W. R. Meyer, Impaired glucose tolerance in pregnant women with polycystic ovary syndrome, Obstet Gynecol, vol.94, pp.194-201, 1999.

E. Raffone, P. Rizzo, and V. Benedetto, Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women

. Endocrinol, , vol.26, pp.275-80, 2010.

K. Rautio, J. S. Tapanainen, A. Ruokonen, and L. C. Morinpapunen, Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study, Hum Reprod, vol.21, issue.6, pp.1400-1407, 2006.

R. Rebar, H. L. Judd, and S. S. Yen, Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome, J Clin Invest, vol.57, pp.1320-1329, 1976.

L. Regan, E. J. Owen, and H. S. Jacobs, Hypersecretion of luteinising hormone, infertility, and miscarriage, Lancet, vol.336, pp.1141-1145, 1990.

R. N. Richards, Electrolysis for the treatment of hypertrichosis and hirsutism, Skin Therapy Lett, vol.4, issue.6, pp.3-4, 1999.

R. S. Rittmaster, Peripheral actions of androgens, Androgen excess disorders in women, pp.63-71, 1997.

G. Robin, C. Richard-proust, and S. Jonard-catteau, Syndrome des ovaires polymicrokystiques, Encycl Méd Chir, vol.10027, p.10, 2007.

D. Romualdi, M. Guido, M. Ciampelli, M. Giuliani, F. Leoni et al., Selective effects of pioglitazone on insulin and androgen abnormalities in normo-and hyperinsulinaemic obese patients with polycystic ovary syndrome, Hum Reprod, vol.18, issue.6, pp.1210-1218, 2003.

R. L. Rosenfield, What every physician should know about polycystic ovary syndrome, Dermatol Ther, vol.21, pp.354-61, 2008.
DOI : 10.1111/j.1529-8019.2008.00217.x

A. Rossi, C. Cantisani, and L. Melis, Minoxidil use in dermatology, side effects and recent patents. Recent Pat Inflamm Allergy Drug Discov, 2012.
DOI : 10.2174/187221312800166859

N. Sahli, B. Salem-hachmi, L. Haouat, and E. , PA052: L'hypertension artérielle au cours du syndrome des ovaires polykystiques (SOPK)
DOI : 10.1016/j.ando.2015.07.213

D. 'endocrinologie, , vol.76, p.367, 2015.

S. Sahmay, N. Atakul, and B. Aydogan, Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome, Acta Obstet Gynecol Scand, vol.92, pp.1369-74, 2013.

S. Sam, R. S. Legro, P. A. Essah, T. Apridonidze, and A. Dunaif, Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome, Proc Natl Acad Sci. USA, vol.103, pp.7030-7035, 2006.

Z. Santos, P. Avci, and M. R. Hamblin, Drug discovery for alopecia: gone today, hair tomorrow, Expert Opin Drug Discov, vol.10, issue.3, pp.269-92, 2015.

M. Sasseville and . Le-rôle-des-phosphodiestérases-dans-le-follicule-ovarien, Figure 2: La stéroïdogénèse et le modèle "2 cellules, 2 gonadotrophines, 2007.

M. E. Sawaya and J. Shapiro, Androgenetic alopecia. New approved and unapproved treatments, Dermatol Clin, vol.18, pp.47-61, 2000.

J. Schenker, S. Yarkoni, and M. Granat, Multiple pregnancies following induction of ovulation, Fertil Steril, vol.35, pp.105-128, 1981.

U. Schlemmer, W. Frølich, R. M. Prieto, and F. Grases, Phytate in foods and significance for humans: food sources, intake, processing, bioavailability, protective role and analysis, Mol. Nutr. Food Res, p.53, 2009.

D. C. Schoot, W. C. Hop, F. H. De-jong, T. J. Van-dessel, and B. C. Fauser, Initial estradiol response predicts outcome of exogenous gonadotropins using a step-down dose regimen for induction of ovulation in polycystic ovary syndrome, Fertil Steril, vol.64, issue.6, pp.1081-1088, 1995.

M. Scioscia, M. A. Paine, K. Gumaa, C. H. Rodeck, and T. W. Rademacher, Release of inositol phosphoglycan P-type by the human placenta following insulin stimulus: a multiple comparison between preeclampsia, intrauterine growth restriction, and gestational hypertension, J Matern Fetal Neonatal Med, vol.21, issue.8, pp.581-586, 2008.

D. W. Shenenberger and L. M. Utecht, Removal of unwanted facial hair, Am Fam Physician, vol.66, issue.10, pp.1907-1918, 2002.

S. B. Shrivastava, Diffuse hair loss in an adult female: Approach to diagnosis and management, Indian J Dermatol Venereol Leprol, vol.75, pp.20-28, 2009.

R. Sinclair, M. Patel, and T. L. Dawson, Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness, Br J Dermatol, vol.165, issue.3, pp.12-20, 2011.

R. Sitruk-ware, Pharmacological profile of progestins, Maturitas, pp.277-83, 2004.

S. R. Smith, D. J. Piacquadio, B. Beger, and C. Littler, Eflornithine cream combined with laser therapy in the management of unwanted facial hair growth in women: a randomized trial, Dermatol Surg, vol.32, pp.1237-1280, 2006.

, Traitement de l'acné par voie locale et générale, 2015.

C. G. Solomon, F. B. Hu, A. Dunaif, and E. Rich, Menstrual cycle irregularity and risk for future cardiovascular disease, J Clin Endocrinol Metab, vol.87, issue.5, pp.2013-2020, 2002.

P. M. Spritzer, K. O. Lisboa, S. Mattiello, and F. Lhullier, Spironolactone as a single agent for long-term therapy of hirsute patients, Clin Endocrinol (Oxf), vol.52, pp.587-94, 2000.
DOI : 10.1046/j.1365-2265.2000.00982.x

J. J. Stachecki and D. R. Armant, Transient release of calcium from inositol 1,4,5-trisphosphate-specific stores regulates mouse preimplantation development

. Development, , vol.122, pp.2485-96, 1996.

K. Stamets, D. S. Taylor, A. Kunselman, L. M. Demers, C. L. Pelkman et al., A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome, Fertil Steril, vol.81, pp.630-637, 2004.

F. Z. Stanczyk, Pharmacokinetics and potency of progestins used for hormone replacement therapy contraception, Rev Endocr Metab Disord, vol.3, pp.211-235, 2002.

I. F. Stein and M. L. Leventhal, Amenorrhea associated with bilateral polycystic ovaries, Am J Obstet Gynecol, vol.29, pp.181-91, 1935.

D. R. Stewart, B. Dombroski, and M. Urbanek, Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity, J Clin Endocrinol Metab, vol.91, pp.4112-4119, 2006.

, Stop calvitie: Comprendre et traiter l'alopécie androgénétique, 2015.

T. H. Sun, D. B. Heimark, and T. Nguygen, Both myoinositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls, Biochem Biophys Res Commun, vol.293, pp.1092-1100, 2002.

B. A. Swiglo, M. Cosma, D. N. Flynn, D. M. Kurtz, M. L. Labella et al., Antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials, J Clin Endocrinol Metab, vol.93, pp.1153-60, 2008.

K. Takayama, T. Fukaya, and H. Sasano, Immunohistochemical study of steroidogenesis and cell proliferation in polycystic ovarian syndrome, Hum Reprod, vol.11, pp.1387-92, 1996.

E. Talbott, D. Guzick, A. Clerici, S. Berga, K. Detre et al., Coronary heart disease risk factors in women with polycystic ovary syndrome, Arterioscler Thromb Vasc Biol, vol.15, pp.821-827, 1995.

T. Tang, J. Glanville, C. J. Hayden, D. White, J. H. Barth et al., Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, doubleblind multicentre study, Hum Reprod, vol.21, issue.1, pp.80-89, 2006.

T. Tang, J. M. Lord, and R. J. Norman, Insulinsensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility, Cochrane Database Syst Rev, vol.5, p.3053, 2012.

E. Tasali, E. Van-cauter, and D. A. Ehrmann, Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome, J Clin Endocrinol Metab, vol.91, issue.1, pp.36-42, 2006.

T. Filho, F. L. Baracat, E. C. Lee, and T. H. , Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome

, J Clin Endocrinol Metab, vol.87, pp.1337-1381, 2002.

A. Torre and H. Fernandez, Le syndrome des ovaires polykystiques (SOPK), J Gynecol Obstet Biol Reprod (Paris), vol.36, pp.423-469, 2007.
DOI : 10.1016/j.jgyn.2007.04.002

A. Torre and H. Fernandez, Le syndrome des ovaires polykystiques (SOPK), J Gynecol Obstet Biol Reprod (Paris), vol.36, p.426, 2007.
DOI : 10.1016/j.jgyn.2007.04.002

A. Torre and H. Fernandez, Le syndrome des ovaires polykystiques (SOPK), J Gynecol Obstet Biol Reprod (Paris), vol.36, p.427, 2007.
DOI : 10.1016/j.jgyn.2007.04.002

K. A. Toulis, D. G. Goulis, E. M. Kolibianakis, and C. A. Venetis,

, diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a meta-analysis

, Fertil Steril, vol.92, pp.667-77, 2009.

B. Trolle and F. F. Lauszus, Risk factors for glucose intolerance in Danish women with polycystic ovary syndrome, Acta Obstet Gynecol Scand, vol.84, issue.12, pp.1192-1198, 2005.

S. Tucci, W. Futterweit, and E. S. Concepcion, Evidence for association of polycystic ovary syndrome in caucasian women with a marker at the insulin receptor gene locus, J Clin Endocrinol Metab, vol.86, pp.446-455, 2001.

I. Tummon, L. Gavrilova-jordan, M. C. Allemand, and D. Session, Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review, Acta Obstet Gynecol Scand, vol.84, pp.611-617, 2005.

V. Unfer, G. Carlomagno, G. Dante, and F. Facchinetti, Effects of myo-inositol in women with PCOS: A systematic review of randomized controlled trials

, Gynecol Endocrinol, vol.28, pp.509-524, 2012.

V. Unfer, G. Carlomagno, E. Papaleo, S. Vailati, M. Candiani et al., Hyperinsulinemia alters myoinositol to d-chiroinositol ratio in the follicular fluid of patients with PCOS, Reprod Sci, vol.21, pp.854-862, 2014.

V. Unfer, G. Carlomagno, P. Rizzo, E. Raffone, and S. Roseff, Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial, Eur. Rev. Med. Pharmacol. Sci, vol.15, pp.452-459, 2011.

M. Urbanek, R. S. Legro, and D. A. Driscoll, Thirtyseven candidate genes for polycystic ovary syndrome : strongest evidence for linkage is with follistatin, Proc Natl Acad Sci USA, vol.96, pp.8573-8581, 1999.

M. Urbanek, A. Woodroff, and K. G. Ewens, Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2, J Clin Endocrinol Metab, vol.90, pp.6623-6632, 2005.

J. Van-der-donk, J. Hunfeld, and J. Passchier, Quality of life and maladjustment associated with hair loss in women with alopecia androgenetica, Social Science and Medicine, vol.38, issue.1, pp.159-63, 1998.